United States (USA) Respiratory Care Devices Market Overview, 2031

The respiratory devices market in the United States has progressed alongside improvements in critical care and the management of chronic illnesses, backed by a healthcare system that utilizes advanced technology. It began with basic mechanical ventilators and systems for delivering oxygen in hospitals, but the market grew with the introduction of portable inhalers, nebulizers, and non-invasive ventilation options like CPAP and BiPAP machines. Over the years, manufacturers have created different product types, including smart inhalers, home ventilators, and wearable monitors for respiratory health. Essentially, respiratory devices are medical tools aimed at helping, monitoring, or enhancing lung function by ensuring proper airflow, oxygen supply, and gas exchange. These devices tackle real-world issues like asthma, COPD, sleep apnea, and respiratory failure, leading to better results and improved quality of life for patients. Their effectiveness has risen markedly due to AI-powered monitoring, cloud integration, and remote patient care. Ongoing research and development from top companies promote greater accuracy, better patient adherence, and usability in home settings. Regulatory supervision through FDA approvals, HIPAA adherence, ISO regulations, and quality certifications guarantees safety, data protection, and clinical trustworthiness, fostering widespread usage.

According to the research report, " US Respiratory Devices Market Overview, 2031," published by Bonafide Research, the US Respiratory Devices market is expected to reach a market size of more than USD 14.43 Billion by 2031. The market for respiratory devices in the United States stands out as one of the most active and important sectors in the medical device market. Worth billions, it shows consistent growth, with predictions indicating a compound annual growth rate in the middle to upper single digits in the upcoming years. This growth is fueled by various demographic, clinical, and technological elements that are transforming patient treatment and the delivery of healthcare. A significant trend is the increasing need for respiratory care solutions that can be used at home. Individuals with chronic illnesses like COPD, asthma, and sleep apnea are more frequently using portable oxygen concentrators, CPAP machines, and connected monitoring systems, which promote greater independence and a better quality of life. The adoption of digital technologies into respiratory devices has hastened this shift, allowing for remote monitoring, personalized therapy modifications, and smooth integration with telehealth services. This digital evolution not only improves patient results but also lessens the pressure on hospitals and clinics. Major firms such as Philips, ResMed, and Medtronic have positioned themselves as leading innovators, providing a wide range of products that include ventilators, inhalation devices, sleep therapy equipment, and cutting-edge digital respiratory solutions. Their commitment to ongoing innovation guarantees that patients access more effective, user-friendly, and connected tools.

US Respiratory Devices market by product type is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. The segmentation of the respiratory devices sector in the U.S. according to product category illustrates the nation’s developed healthcare framework, significant prevalence of chronic illnesses, and a robust adoption of technology-enhanced healthcare solutions. Therapeutic devices hold the largest market share, largely due to the extensive utilization of ventilators, CPAP/BiPAP units, oxygen concentrators, and nebulizers in both hospital and homecare environments. These instruments are essential for treating chronic respiratory ailments like COPD and sleep apnea, especially within the older demographic. Monitoring devices have experienced significant growth, fueled by the rising demand for continuous respiratory tracking in both urgent care and remote settings. Tools like pulse oximeters, capnography machines, and connected respiratory monitors are increasingly being linked with telehealth systems, allowing healthcare providers to monitor patient progress in real time. Diagnostic devices, such as spirometers and systems for pulmonary function testing, are crucial for early diagnosis and tracking disease development, particularly in outpatient facilities and pulmonary specialist clinics. Innovations like AI-driven diagnostics and cloud-based analytics are improving both the precision of diagnostics and the efficiency of workflows. Consumables and accessories including masks, breathing circuits, filters, and sensors create an ongoing revenue stream due to their regular need for replacement and adherence to infection control protocols in the U.S. healthcare environment. Strict FDA regulations and hospital procurement practices further enhance the need for high-quality, certified consumables. The segmentation by product category emphasizes the focus of the U.S. sector on comprehensive respiratory care solutions that integrate therapy, monitoring, and diagnostics, backed by well-established reimbursement frameworks and a mature medical device landscape.

US Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. The end-user breakdown of the U.S. respiratory devices market showcases a varied care delivery structure that includes acute, outpatient, and home care environments. Hospitals are the primary end users due to the high rate of patient admissions, the presence of intensive care units, and the necessity for advanced ventilators, diagnostic tools, and respiratory monitoring devices. Teaching hospitals and large healthcare systems are leading the way in adopting advanced technological devices, benefiting from substantial capital budgets and ongoing clinical research. Ambulatory Care Centers ACCs are quickly becoming a burgeoning segment, encouraged by the shift towards outpatient services and efforts to control costs in the U.S. healthcare landscape. These centers increasingly employ portable diagnostic tools, spirometers, and non-invasive respiratory support methods for managing chronic diseases without requiring hospital stays. Home care environments are one of the fastest-growing segments, driven by an increasing elderly population, a greater preference for home treatment, and expanded coverage for durable medical devices. Devices for home oxygen therapy, sleep apnea treatments, and remote monitoring are widely used, especially for the long-term management of COPD and sleep apnea. Additional end users such as long-term care facilities, rehabilitation centers, and emergency medical services contribute to ongoing demand for portable and resilient respiratory devices. The significant expansion of home care and outpatient services reflects a substantial transition in the U.S. toward decentralized respiratory care, backed by telehealth developments, digital monitoring, and a focus on value-based healthcare solutions.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"